Literature Review: Preference and Satifaction of Chronic Obstructive Pulmonary Disease (COPD) Patient Againts Genuair Inhalers
DOI:
https://doi.org/10.35747/hmj.v7i1.661Keywords:
COPD, Genuair Inhalers, Satifaction patientAbstract
Chronic Obstructive Pulmonary Disease (COPD) is one of the third leading causes of death in the world. Correct use of inhalers is important in the pharmacological treatment of chronic obstructive pulmonary disease. Choosing the most appropriate inhaler for the patient is likely to influence attitudes, increase adherence to therapy, and have therapeutic benefits. This literature review aims to examine the preferences and satisfaction of COPD patients with Genuair inhalers. A literature search was carried out using the Pubmed, ProQuest, Google Scholar, European Respiratory Journal and Sciencedirect databases with literature limitations from 2012 to 2022, with inclusion criteria a). English articles b). patients diagnosed with COPD c). using a genuair/pressair inhaler to produce 772 journals. Then a selection process was carried out and 14 journals were obtained. Based on the results of the literature review, it is known that eight studies show that Genuair is preferred by COPD patients. Each inhaler has advantages and disadvantages that can have an impact on use, patient satisfaction and adherence to therapy which can affect clinical outcomes. The Genuair inhaler is designed to provide multi-sensory feedback, a trigger threshold function to prevent double dosing and a lock-out mechanism to prevent overuse of the inhaler after the last dose has been used. The Genuair inhaler is suitable for COPD patients, especially for those who are less compliant with medication due to breathing difficulties.
References
Ahn June Hong, Chung Jin Hong, Shin Kyeong Cheol, Choi Eun Young, Jin Hyun Jung, Lee Mi Suk, Nam Mi Jeong, Lee Kwan Ho. (2019). Critical Inhaler Handling Error Is an Independent Risk Factor for Frequent Exacerbations of Chronic Obstructive Pulmonary Disease: Interim Results of a Single Center Prospective Study. International Journal of COPD 14: 2767–75.
Beier Jutta, Kirsten Anne Marie, Mrûz Robert, Segarra Rosa, Chuecos Ferran, Caracta Cynthia, Gil Esther Garcia . (2013). Efficacy and Safety of Aclidinium Bromide Compared with Placebo and Tiotropium in Patients with Moderate-to-Severe Chronic Obstructive Pulmonary Disease: Results from a 6-Week, Randomized, Controlled Phase Iiib Study. COPD: Journal of Chronic Obstructive Pulmonary Disease 10(4): 511–22.
Blasi Francesco, Canonica GiorgioWalter, Centanni Stefano, Mereu Carlo, Bernabei Roberto, Paolisso Giuseppe, Incalzi Raffaele Antonelli, Corsico Angelo, Di Marco Fabiano, Milanese Manlio, Pagano Francesco, Santus Pierachille, Scichilone Nicola, Sumberesi Massimo, Braido Fulvio, Baiardini, Ilaria (2016). “Genuair® Usability Test: Results of a National Public Survey of the Elderly.” COPD: Journal of Chronic Obstructive Pulmonary Disease 13(3): 367–71.
Dal Negro, Roberto W., and Massimiliano Povero. (2016a). Acceptability and Preference of Three Inhalation Devices Assessed by the Handling Questionnaire in Asthma and COPD Patients.” Multidisciplinary Respiratory Medicine, 11(1): 1–8.
Dal Negro, Roberto W., and Massimiliano Povero. (2016b). Dry-Powder Inhalers in Patients with Persistent Airflow Limitation: Usability and Preference. Multidisciplinary Respiratory Medicine, 11(1): 1–9.
Dal Negro, Roberto W., Paola Turco, and Massimiliano Povero. (2019). “Patients’ Usability of Seven Most Used Dry-Powder Inhalers in COPD. Multidisciplinary Respiratory Medicine, 14(1): 14–19.
Jang Jong Geol, Lee Kwan Ho, Chung Jin Hong, Shin Kyeong-Cheol, Choi Eun Young, Jin Hyun Jung, Ahn June Hong 2022. “Assessment of Inhaler Satisfaction and Determinants of High Satisfaction Among Korean COPD Patients.” Journal of Korean Medical Science, 37(46): 1–10.
Janknegt Robert, Johan Kooistra, Esther Metting, and Richard Dekhuijzen. (2021). Rational Selection of Inhalation Devices in the Treatment of Chronic Obstructive Pulmonary Disease by Means of the System of Objectified Judgement Analysis (SOJA). European Journal of Hospital Pharmacy, 28(2): 1–6.
Lee Ha Youn, Song Jin Hwa, Won Ha Kyeong, Park Yeonkyung, Chung Keun Bum, Lim Hyo Jeong, Ahn Young Mee, Lee Byoung Jun. (2021). Comparing Inhaler Use Technique Based on Inhaler Type in Elderly Patients with Respiratory Disease. Tuberculosis and Respiratory Diseases, 84(1): 46–54.
Lopez A. D., Shibuya K., Rao C., Mathers C. D., Hansell A. L., Held L. S., Schmid V., Buist S.. (2006). Chronic Obstructive Pulmonary Disease: Current Burden and Future Projections. European Respiratory Journal, 27(2): 397–412.
Magnussen H., Watz H., Zimmermann I., Macht S., Greguletz R., Falques M., Jarreta D., Garcia Gil E. (2009). Peak Inspiratory Flow through the Genuair® Inhaler in Patients with Moderate or Severe COPD. Respiratory Medicine, 103(12): 1832–37.
Ohbayashi Hiroyuki, Sahori Kudo, and Masatake Ishikawa. (2017). Inhaler Operability and Patient Satisfaction Regarding Genuair® and Respimat® Inhalers for Chronic Obstructive Pulmonary Disease: A Randomized Crossover Study. Pulmonary Therapy, 3(1): 173–85.
Palen Job van der, Ginko Thomas, Kroker Axel, Valk Paul van der, Goosens Martijn, Padulles Laura, Seoane Beatriz, Rekeda Ludmyla, Gil Esther Garcia. 2012. “Comparison of the Preference, Satisfaction, and Critical Errors Made With Genuair ® and HandiHaler ® in Patients with COPD. Chest, 142(4): 717A.
Pascual Sergi, Feimer Jan, De Soyza Anthony, Sauleda Roig Jaume, Haughney John, Padullés Laura, Seoane Beatriz, Rekeda Ludmyla Ribera Anna, Chrystyn Henry. (2015). “Preference, Satisfaction and Critical Errors with Genuair and Breezhaler Inhalers in Patients with COPD: A Randomised, Cross-over, Multicentre Study.” npj Primary Care Respiratory Medicine 25:1-7
Plaza Vicente, Giner Jordi, Calle Myriam, Rytilä Paula, Campo Carlos, Ribó Paula, Valero Antonio (2018). Impact of Patient Satisfaction with His or Her Inhaler on Adherence and Asthma Control. Allergy and Asthma Proceedings, 39(6): 437–44.
Price David, Keininger Dorothy L., Viswanad Boomi, Gasser Matthias, Walda Susann, Gutzwiller Florian S..(2018). “Factors Associated with Appropriate Inhaler Use in Patients with COPD – Lessons from the REAL Survey.” International Journal of COPD 13: 695–702.
Ruessel Katharina, Eva Luecke, and Jens Schreiber. (2020). Inhaler Devices in a Geriatric Patient Population: A Prospective Cross-Sectional Study on Patient Preferences. Patient Preference and Adherence, Volume 14: 1811–22.
Schreiber Jens, Tina Sonnenburg, and Eva Luecke. 2020. Inhaler Devices in Asthma and COPD Patients - A Prospective Cross-Sectional Study on Inhaler Preferences and Error Rates. BMC Pulmonary Medicine, 20(1): 1–12.
Vogelmeier, Claus, Paggiaro, Pier Luigi Dorca, Jordi Sliwinski, Pawel Mallet, Marcel Kirsten, Anne Marie Beier, Jutta Seoane, Beatriz Segarra, Rosa Maria Leselbaum, Anne. (2016). Efficacy and Safety of Aclidinium/ Formoterol versus Salmeterol/Fluticasone: A Phase 3 COPD Study. European Respiratory Journal, 48(4): 1030–39
